No COVID-19 Detour for Global Hematology Therapies

Rachel Narozniak, MA
Published: Wednesday, Apr 29, 2020
Brian
Lindberg

Brian Lindberg

With travel restrictions and reduced transportation options, the global spread of coronavirus disease 2019 (COVID-19) has disrupted international networks that supply patients with biological materials needed for sophisticated hematologic therapies.
... to read the full story
To Read the Full Story

View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Publication Bottom Border
Border Publication
x